Have you explored the #NACLC26 program?
Discover educational sessions and expert discussions on the latest advances in #lungcancer prevention, diagnosis, and treatment.
Join us Dec. 4–6 in Scottsdale!
bit.ly/3VHjvD7 @ASCO
Final days to apply!
The IASLC Adi F. Gazdar Fellowship Grant offers $50,000 to support postdoctoral #lungcancer researchers.
Deadline: January 14.
Learn more: bit.ly/3UD0b9O
🏆 Who has made a lasting impact on thoracic oncology?
The IASLC Distinguished Service Awards recognize exceptional leaders whose contributions to research, patient care, and the global thoracic oncology community have helped shape the field.
As nominations open for the 2027 awards, we invite IASLC members to reflect on the individuals whose leadership and achievements deserve recognition.
Meet our 2026 Distinguished Service Award recipients, discover their contributions, and nominate someone who inspires you.
iaslc.org/distinguished-serv…
#IASLC #ThoracicOncology #IASLCAwards
IASLC retweeted
Patients with pulmonary carcinoid have a well-differentiated, though rare, tumor. But not much is known about the disease’s response to DLL3-targeted bispecific T-cell engager #tarlatamab. @JessieStuart316 et al. analyzed the response in 11 patients at Memorial Sloan Kettering Cancer Center and found that #tarlatamab is a promising treatment option for patients with PC.
Read more here: bit.ly/4suaCsN
#LungCancerResearch #JTO
New research, new perspectives from #ESMO26!
In a Spanish-language episode of #LungCancerConsidered, Drs. @NarjustFlorezMD and @AnaVManana unpack DeLLphi-305, SAFFRON, Krascendo 1, and MOIO, exploring advances in targeted therapies and immunotherapy.
🎧 bit.ly/4z0AJcy
#LungCancer #ThoracicOncology @myESMO
IASLC retweeted
How we talk about lung cancer matters. Created by patient advocates to help physicians reduce stigma, IASLC’s language guide can also help you support someone with lung cancer through compassionate words. Download and share: bit.ly/IASLCLangGuide
#LCAM
Radiology professionals: We still want to hear from you!
Share your priorities with IASLC and help inform future opportunities and resources for the #radiology community.
Take the survey: bit.ly/4yaE1JV
Every cancer patient deserves compassion.
This #LCAM, @QuistMorten reminds us that people with lung cancer face stigma and judgment when they deserve understanding, support, and quality care. 💙 Support lung cancer research!
Your donation will be matched dollar for dollar, up to $10K. bit.ly/LCAM26s
🇰🇷 Hear the latest from #WCLC26 in Korean!
@chulkimMDis joined by Dr. Ji-Youn Han, Dr. Tae Min Kim & Dr. Sehhoon Park for a look at key thoracic oncology research and takeaways from the conference.
🎧 bit.ly/4y9jYeS
#WCLCKorea #LungCancer #LungCancerConsidered
IASLC retweeted
#LCAM26: #JTO Editor-in-Chief @DrAlexAdjei shares his thoughts in the editorial "The Price of Progress in Lung Cancer: Global Disparities, Drug Costs, and the Challenge of Equitable Access"
🆓 access: jto.org/article/S1556-0864(2…
@JTOonline @IASLC #LCAM @ElsevierConnect
IASLC retweeted
An outstanding lineup of faculty and presentations awaits at ITMIG-LALCA 2026!
One registration provides on-site access to both conferences.
Join us in São Paulo, Brazil, November 12–14, 2026!
Register here:
conferences.iaslc.org/e/itmi…
@IASLC @Itmig_society
How we talk about lung cancer matters. Created by patient advocates to help physicians reduce stigma, IASLC’s language guide can also help you support someone with lung cancer through compassionate words. Download and share: bit.ly/IASLCLangGuide
#LCAM
Expert perspectives from #ESMO26! 🎙️
In the latest #LungCancerConsidered episode, Drs. @StephenVLiu and @NarjustFlorezMD welcome @DrJNaidoo @sands_jacob and @FSkoulidis to share insights from across the thoracic oncology community.
🎧 Listen now: bit.ly/4BNcJML
#LungCancer #ThoracicOncology
The conversations at #NACLC26 go beyond the sessions!
Connect with colleagues, exchange ideas, and explore the latest advances in thoracic oncology, Dec. 4–6 in Scottsdale.
Join us: bit.ly/3VHjvD7
#LungCancer @ASCO
⏰ Three weeks left to submit your abstract for #TTLC27!
Share your research and contribute to the latest conversations around targeted therapies and precision medicine in #lungcancer.
📅 Deadline: Nov. 23
Submit: bit.ly/4jHRxB1
Lung cancer risk reduction goes beyond tobacco control.
Understanding risk factors such as tobacco use, secondhand smoke, cooking oil fumes, radon, and air pollution can help us make informed choices and reduce exposure.
At the 2026 World Conference on Lung Cancer, @JLCastroGarcia, @WHO Director-General Special Envoy for Chronic Respiratory Diseases, emphasized the importance of a comprehensive approach to lung cancer risk reduction.
🎧 Listen to his remarks on why reducing lung cancer risk requires addressing more than tobacco use.
#LungCancerAwarenessMonth #LCAM2026 #LungCancerRiskReduction
🇬🇪 A challenging case. Multiple specialties. Evolving treatment options.
In a new Georgian-language #LungCancerConsidered episode, @EMariamidze joins Drs. Mariam Tchiabrishvili and Lasha Khmaladze for a virtual tumor board on advanced EGFR-mutated NSCLC.
The experts explore molecular testing, EGFR TKIs, brain metastases, and barriers to accessing care in Georgia.
🎧 Listen: bit.ly/47MQ1qi
#LungCancer #ThoracicOncology #EGFR
During #WCLC26, Dr. Tae Hee Hong presented the results of a retrospective analysis of the association between the 2025 IASLC LUSC grading system and survival outcomes.
🔗 More details in ILCN: bit.ly/4Bvc16B
#LCSM
🫁 November is #LungCancerAwarenessMonth!
Throughout November, we're spotlighting IASLC members and innovations advancing lung cancer research and care worldwide.
Join us in raising awareness and supporting the IASLC Foundation.
Donate: bit.ly/LCAM26s
